TABLE 5.

Adverse events by treatment arm and group

Adverse event(s)	No. (%) of women						P value
	3 days			5 days
	Pregnant	Nonpregnant	All	Pregnant	Nonpregnant	All
Headache	6	6	12 (25)	3	3	6 (12.5)	0.12
Gastrointestinal disorders	1	0	1 (2)	5	2	7 (14.6)	0.03
Dizziness	3	2	5 (10.4)	1	2	3 (6.3)	0.49
Influenza-like syndrome	3	0	3 (6.3)	0	1	1 (2)	0.31
Back pain	1	0	1 (2)	1	0	1 (2)	1
Epistaxis	1	0	1 (2)	1	0	1 (2)	1
High blood pressure	0	0	0 (0)	0	2	2 (4.2)	0.16
Decreased total WBCs	2	2	4 (8.3)	0	1	1 (2)	0.34
Decreased neutrophils	2	3	5 (10.4)	1	0	1 (2)	0.206
Increased ALT	1	0	1 (2)	3	3	6 (12.5)	0.23
Increased AST	3	5	8 (16.6)	2	3	5 (10.4)	0.55
Increased creatinine	4	3	7 (14.6)	5	4	9 (18.8)	0.60
Genital infection	0	0	0 (0)	2	0	2 (4.2)	0.16